This randomized clinical trial examines the efficacy of diacerein, compared with placebo, on knee pain in people with knee osteoarthritis who have substantial knee pain and inflammation. from JAMA Internal Medicine Online First https://ift.tt/CxNpfvg

This essay discusses the author’s experience as a bone marrow donor. from JAMA Internal Medicine Online First https://ift.tt/rC5DcoA

This Viewpoint discusses the Cardiff Model for Violence Prevention and how implementation in the US could use law enforcement and emergency department data to inform violence prevention strategies. from JAMA Internal Medicine Online First https://ift.tt/jKzvuAk

This Viewpoint describes the Centers for Medicare & Medicaid Services’ new payment policy to establish and maintain buffer supplies of designated essential medicines and suggests additional reforms to improve this policy. from JAMA Health Forum New Online https://ift.tt/7EZaOVy

This JAMA Forum discusses key changes in the 2025-2030 Dietary Guidelines for Americans, confusion about the new food pyramid, implications for population health, and the role for health professionals. from JAMA Health Forum New Online https://ift.tt/cvsabjX

This Viewpoint discusses different ways to measure the return on investment on clinician-facing artificial intelligence tools as the technology advances. from JAMA Internal Medicine Online First https://ift.tt/wMxrsTy

This Viewpoint discusses the potential harms of online sports betting, gaps in prevention and treatment, and protective policy shifts. from JAMA Health Forum New Online https://ift.tt/Iu85A3Q

This JAMA Forum discusses the emerging threats, health consequences, and opportunities to develop policies and programs to improve the health and well-being of the medically underserved population along the US-Mexico border. from JAMA Health Forum New Online https://ift.tt/ZiDu6jp

This Viewpoint outlines recent evidence on outcomes of transcatheter aortic valve replacement (TAVR) in patients at low risk and younger adults. from JAMA Internal Medicine Online First https://ift.tt/Rr3JoYy

This Viewpoint discusses the lawfulness and credibility of the US Food and Drug Administration’s recent move to using expert panels rather than advisory committees for decision-making. from JAMA Health Forum New Online https://ift.tt/vUMET7p

This JAMA Forum discusses the rationale for health savings accounts (HSAs), the changing health insurance environment, and the reasons why HSAs are no longer containing costs. from JAMA Health Forum New Online https://ift.tt/xm6W0Ho